S 9221 NY
Establishes a medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants test strip program
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Summary
NY S 9221 directs the Office of Alcoholism and Substance Abuse Services to establish a program providing free drug test strips to individuals to detect medetomidine, benzodiazepine, nitazenes, and other harmful contaminants in drugs. The bill requires the Office of Alcoholism and Substance Abuse Services, in cooperation with the Department of Health, to develop and conduct a public awareness and educational campaign about the dangers of these harmful drug contaminants.
AI-generated plain-language summary of the bill (from the OpenStates abstract — no full text available yet) — neutral, and may be imperfect.
Official abstract
Directs the commissioner of the office of alcoholism and substance abuse services to establish a program for individuals to receive free drug test strips to detect the presence of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants; directs the commissioner of the office of alcoholism and substance abuse services, in cooperation with the commissioner of the department of health, to develop and conduct a public awareness and educational campaign on the dangers of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants.
Sponsor (1)
- Christopher Ryan Democratic · primary
Action history (5)
- Feb 17, 2026 REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS · upper
- May 21, 2026 REPORTED AND COMMITTED TO FINANCE · upper
- Jun 4, 2026 COMMITTEE DISCHARGED AND COMMITTED TO RULES · upper
- Jun 4, 2026 ORDERED TO THIRD READING CAL.1742 · upper
- Jun 4, 2026 SUBSTITUTED BY A9001 · upper
Full text
The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.
Comments
Data from OpenStates. View on OpenStates →
Comments